Article

Femtosecond laser's latest version shows increased efficiency, performance

The latest version of a proprietary femtosecond laser (iFS, Abbott Medical Optics) offers a 150-kHz repetition rate and expanded options for flap customization.

Key Points

"The newest version of this femtosecond laser is providing surgeons with many attributes desired in an instrument used for LASIK flap creation," said Dr. Lindstrom, founder and attending surgeon, Minnesota Eye Consultants, Minneapolis. "It effectively creates easy-to-lift flaps with increased efficiency and minimal inflammation . . . and allows for greater customization, including options providing stronger flap adherence.

"As this technology becomes better and better, . . . surgeons [may] also be able to measure the improvements in terms of enhanced clinical outcomes," he added.

"Patients still feel a little pressure when the suction ring is on, but the procedure is now very quick, so the duration of any discomfort is much shorter," he said.

The faster repetition rate also allows the use of tighter raster patterns and lower energy settings. As alternatives to the classic 8 X 8 µm or 9 X 9 µm pulse separations, Dr. Lindstrom said that some surgeons are using a 5 X 5, 6 X 6, or 7 X 7 µm pattern.

"Tighter [raster patterns] and lower energy reduce inflammation and the risk of diffuse lamellar keratitis as well as result in smoother beds and easier flap lifts," he said.

Options for flap customization also have been expanded. Surgeons now can create elliptical (oval) flaps instead of simply round flaps, and they can modify the side cut angle to create a bevel-in configuration with an inverted angle of up to 150°.

"An oval flap has potential advantages in some procedures, especially when treating astigmatism, and it also helps to move the hinge out of the way of the ablation," Dr. Lindstrom said. "In addition, an oval flap helps preserve vital corneal fibers in the periphery that contribute to corneal biomechanical strength and minimizes nerve resection to reduce the risk of dry eye."

Emerging evidence on the benefits of the inverted side cut has been very interesting, he said.

"Initially, I was unsure if an inverted side cut would have positive or negative consequences, but in theory, it seemed it may have benefits for improving flap adhesion strength and reducing epithelial ingrowth, especially after enhancement," Dr. Lindstrom said. "Subsequently, research conducted by Michael Knorz, MD, in animal eyes and by Arturo Chayet, MD, in humans confirm that the bevel-in side cut is associated with stronger adhesion, and this technique is being adopted by most surgeons with access to the new femtosecond laser."

Flap repositioning also is easier using the bevel-in side cut, he said, and data are being collected to investigate the hypothesis that this configuration reduces the incidence of microstriae, macrostriae, and flap slippage.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.